Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin - PubMed (original) (raw)

Affiliations

PMID: 1501117

Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin

N A Darmani et al. J Pharmacol Exp Ther. 1992 Aug.

Abstract

The 5-hydroxytryptamine (5-HT)2 agonist (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and antagonist ketanserin were evaluated for acute and chronic effects on the 5-HT2 receptor-mediated head-twitch response (HTR) in mice. A single dose of DOI resulted in tolerance to the DOI-induced HTR at 24 hr but supersensitivity at 48 hr. This apparent supersensitivity persisted up to 144 hr after the first DOI injection. Chronic once daily DOI administration significantly reduced the HTR frequency (days 2-6), which then returned slowly to control levels by treatment day 13. A 48-hr withdrawal from this chronic regimen produced a similar supersensitivity to that observed after a single DOI injection upon a 48-hr challenge. This effect also persisted up to 144 hr after cessation of chronic treatment. Acute pretreatment with a single injection of ketanserin significantly reduced the DOI-induced HTR frequency when tested 24 and 48 hr, but not 120 hr, after injection of the antagonist. After withdrawal from chronic ketanserin treatment, the DOI-induced HTR was significantly reduced at 24 hr but significantly increased at 48 hr. This enhanced effect subsided when mice were tested with DOI 72 hr after cessation of chronic antagonist treatment. These data suggest that the serotonergic system adapts to chronic exposure of either agonists or antagonists in a fashion distinctly different from that exhibited by other monoamine neurotransmitter systems.

PubMed Disclaimer

Cited by

Synthesis, central nervous system activity, and structure-activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1_H_)-ones.
Rządkowska M, Szacoń E, Kaczor AA, Fidecka S, Kędzierska E, Matosiuk D. Rządkowska M, et al. Med Chem Res. 2014;23(9):4221-4237. doi: 10.1007/s00044-014-0993-1. Epub 2014 Mar 27. Med Chem Res. 2014. PMID: 25132789 Free PMC article.
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. Fantegrossi WE, et al. Pharmacol Biochem Behav. 2008 Jan;88(3):358-65. doi: 10.1016/j.pbb.2007.09.007. Epub 2007 Sep 14. Pharmacol Biochem Behav. 2008. PMID: 17905422 Free PMC article.
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
Canal CE, Morgan D. Canal CE, et al. Drug Test Anal. 2012 Jul-Aug;4(7-8):556-76. doi: 10.1002/dta.1333. Epub 2012 Apr 19. Drug Test Anal. 2012. PMID: 22517680 Free PMC article. Review.
Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
Smith DA, Bailey JM, Williams D, Fantegrossi WE. Smith DA, et al. J Pharmacol Exp Ther. 2014 Dec;351(3):485-91. doi: 10.1124/jpet.114.219337. Epub 2014 Sep 30. J Pharmacol Exp Ther. 2014. PMID: 25271256 Free PMC article.
Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.
Pędzich BD, Medrano M, Buckinx A, Smolders I, De Bundel D. Pędzich BD, et al. Int J Mol Sci. 2022 Dec 4;23(23):15284. doi: 10.3390/ijms232315284. Int J Mol Sci. 2022. PMID: 36499610 Free PMC article.

Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin - PubMed (original) (raw)